top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Hereditary Hemorrhagic Telangiectasia : Recent Advances and Future Challenges
Hereditary Hemorrhagic Telangiectasia : Recent Advances and Future Challenges
Autore Mager Hans-Jurgen
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (228 p.)
Soggetto topico Research and information: general
Soggetto non controllato activin receptor-like kinase 1 (ALK1)
activin-receptor-like kinase 1
ACVRL1
ALK1
angiogenesis
antiangiogenic properties
anticoagulants
antiplatelets
antithrombotic therapy
arteriovenous malformation
arteriovenous malformation (AVM)
arteriovenous malformations (AVMs)
AVM
bazedoxifene
bevacizumab
biomarker
biomarkers
bleeding
bone morphogenetic protein (BMP)
catheter based embolization therapy
cell adhesion
cerebral ischemic lesions
contrast enhanced magnetic resonance angiography
endoglin
Endoglin
endothelial cells
ENG
epistaxis
epistaxis severity score
etamsylate
FK506
gastrointestinal bleeding
genetic disease
genotype-phenotype correlation
guidelines
hereditary hemorrhagic
hereditary hemorrhagic telangiectasia
Hereditary hemorrhagic telangiectasia
Hereditary Hemorrhagic Telangiectasia
hereditary hemorrhagic telangiectasia (HHT)
hereditary hemorrhagic telangiectasia (HHT), second-hit
hereditary hemorrhagic telangiectasia/HHT/osler's disease
HHT
inflammation
life expectancy
liver
long non-coding RNAs
mechanical damage
microRNA
microRNAs
MRI
N-acetylcysteine
nasal endoscopy
nasal ointment
non-coding RNAs
nosebleeds
Osler-Weber-Rendu
pediatrics
plasma
propranolol
propranolol gel
pulmonary arteriovenous malformation
pulmonary arteriovenous malformations
raloxifene
rare disease
rare diseases
safety
screening
shear stress
Smad pathway
Smad4
SMAD4
somatic mutation
sun-induced trauma
survival
tacrolimus
telangiectases
telangiectasia
telangiectasis
tranexamic acid
transcatheter embolotherapy
transforming growth factor beta (TGF-β)
transforming growth factor-beta (TGF-β)
ultrasound
vascular endothelial growth factor (VEGF)
vascular injury
vascular malformations
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Hereditary Hemorrhagic Telangiectasia
Record Nr. UNINA-9910557578003321
Mager Hans-Jurgen  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Looking Forward To The Future of Heparin : : New Sources, Developments and Applications / / Giangiacomo Torri, Jawed Fareed
Looking Forward To The Future of Heparin : : New Sources, Developments and Applications / / Giangiacomo Torri, Jawed Fareed
Autore Torri Giangiacomo
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2018
Descrizione fisica 1 electronic resource (282 p.)
Soggetto topico Chemistry
Soggetto non controllato alginate
edema
Heparin Red
solid lipid nanoparticles
Fe3O4·DA-BSA/HA
dermatan sulfate
sulfated alginate
porcine heparin
theranostics
low-molecular-weight heparin
Arixtra®
biomaterials
hepcidin
ovarian cancer
iron oxide nanoparticles
heparin-induced thrombocytopenia
bone morphogenetic protein (BMP)
hyaluronic acid (HA)
crude heparin
platelets
resistance
sclerostin
LMWH
gremlin
low molecular weight heparin (LMWH)
low molecular weight glycosaminoglycans
human plasma
single crystal X-ray structure
iron homeostasis
noggin
super paramagnetic iron oxide nanoparticles (SPION)
manufacturing methods
paclitaxel (PTX)
brain injury
bovine heparin
inflammation
qNMR
antithrombin
reference standard
quantitative NMR
enoxaparin
danaparoid sodium
NMR
GDNF
orthogonal multi-analytical methods
ternary complex
heparan sulphate
serglycin
bovine serum albumin (BSA)
HSQC
recombinant expression
heparin
heparin oligosaccharides
functional assay
BMP antagonists
intestinal lymphatic absorption
size exclusion chromatography
heparin coating
diagnosis
bioreactor
anemia
proteoglycan
heparin process
PCA
chemometric
fluorescent probe
pharmacopeia
affinity chromatography
component quantitative analysis
Fondaparinux sodium
perylene diimide dyes
thrombin inhibition
extended physicochemical characterization
cisplatin
glycosaminoglycans
TGF-?
chondroitin sulfate
dalteparin
sequence and compositional investigations
molecular weight
magnetic resonance imaging (MRI)
industrial
LC-MS
iduronic acid conformation
heparan sulfate
growth and differentiation factor (GDF)
assay
subarachnoid hemorrhage
ISBN 9783038429500
3038429503
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346841803321
Torri Giangiacomo  
MDPI - Multidisciplinary Digital Publishing Institute, 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui